Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Czerniak

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
The Journal of Urology|September 26, 2014
Clinical outcomes of cT1 micropapillary bladder cancerDaniel L Willis, Mario I Fernandez, Rian J Dickstein, et al.
European Urology Focus|July 30, 2017
Impact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle InvasionMichael J Metcalfe, James E Ferguson, Roger Li, et al.
European Urology|June 12, 2017
Comprehensive Genomic Characterization of Upper Tract Urothelial CarcinomaTyler J Moss, Yuan Qi, Liu Xi, et al.
The Journal of Molecular Diagnostics : JMD|January 1, 2013
Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypesCarmen D Schweighofer, Kevin R Coombes, Tadeusz Majewski, et al.
Genome Research|August 19, 2010
Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancerMarcos R H Estécio, Juan Gallegos, Céline Vallot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinomaJinhee Kim, Eric Jonasch, Angela Alexander, et al.
Blood|February 12, 2011
LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patientsHatice Duzkale, Carmen D Schweighofer, Kevin R Coombes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapyKelly N Blehm, Philippe E Spiess, Jolanta E Bondaruk, et al.
Frontiers in Immunology|November 19, 2024
Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon α gene therapy in a murine bladder cancer modelAlexis R Steinmetz, Morgan Pierce, Alberto Martini, et al.
The Lancet. Oncology|October 5, 2019
Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort studyCarmen D Herling, Kevin R Coombes, Axel Benner, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
The Journal of Urology|September 26, 2014
Clinical outcomes of cT1 micropapillary bladder cancerDaniel L Willis, Mario I Fernandez, Rian J Dickstein, et al.
European Urology Focus|July 30, 2017
Impact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle InvasionMichael J Metcalfe, James E Ferguson, Roger Li, et al.
European Urology|June 12, 2017
Comprehensive Genomic Characterization of Upper Tract Urothelial CarcinomaTyler J Moss, Yuan Qi, Liu Xi, et al.
The Journal of Molecular Diagnostics : JMD|January 1, 2013
Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypesCarmen D Schweighofer, Kevin R Coombes, Tadeusz Majewski, et al.
Genome Research|August 19, 2010
Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancerMarcos R H Estécio, Juan Gallegos, Céline Vallot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinomaJinhee Kim, Eric Jonasch, Angela Alexander, et al.
Blood|February 12, 2011
LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patientsHatice Duzkale, Carmen D Schweighofer, Kevin R Coombes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapyKelly N Blehm, Philippe E Spiess, Jolanta E Bondaruk, et al.
Frontiers in Immunology|November 19, 2024
Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon α gene therapy in a murine bladder cancer modelAlexis R Steinmetz, Morgan Pierce, Alberto Martini, et al.
The Lancet. Oncology|October 5, 2019
Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort studyCarmen D Herling, Kevin R Coombes, Axel Benner, et al.
Pageof 15